CLINICAL_TRIALS
trial_result
· 2017-05-12
Clinical Trial Update: Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders [Phase 2]
Summary
Phase 2 clinical trial update on allogeneic bone marrow transplant for inherited metabolic disorders; study completed with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Mucopolysaccharidosis, Hurler Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-05-12